NIFTY 50▼22,554.65
-15.70 (-0.07%)
SENSEX▼74,286.49
-52.95 (-0.07%)
NIFTY BANK▼48,473.75
-21.20 (-0.04%)
TATA MOTORS▲1,002.10
0.85 (0.08%)
INDIAN RAILWAY FINANCE CORP▼150.15
-0.10 (-0.07%)
SUZLON ENERGY▼41.55
-0.60 (-1.42%)
TATA POWER▲436.65
5.20 (1.21%)
TATA STEEL▲168.20
0.50 (0.30%)
YES BANK▲26.15
0.20 (0.77%)
INDIAN RENEWABLE ENERGY▼166.90
-0.35 (-0.21%)
RELIANCE INDUSTRIES▼2,914.55
-5.40 (-0.18%)
VODAFONE IDEA▼13.45
-0.45 (-3.24%)
RELIANCE POWER▲27.60
0.10 (0.36%)
HDFC BANK▲1,520.15
9.40 (0.62%)
JIO FIN SERVICES LTD▼381.65
-0.65 (-0.17%)
RAIL VIKAS NIGAM▼283.25
-3.90 (-1.36%)
ADANI POWER▼591.35
-1.00 (-0.17%)
ZOMATO▲187.50
2.80 (1.52%)
NHPC▲91.45
0.40 (0.44%)
STATE BANK OF INDIA▼807.40
-5.30 (-0.65%)
INDIAN RAILWAY TOURISM CORP▲1,029.55
1.75 (0.17%)
INDIAN OIL CORP▲170.55
0.35 (0.21%)
MRF▲1,30,210.75
578.05 (0.45%)
ITC▲438.10
0.55 (0.13%)
ADANI GREEN ENERGY▼1,798.80
-13.85 (-0.76%)
JAIPRAKASH POWER VENTURES18.05
0.00 (0.00%)
ADANI PORT & SEZ▼1,329.00
-1.55 (-0.12%)
ADANI ENTERPRISES▼3,097.35
-17.90 (-0.57%)
SAMSRITA LABS LIMITED Share Price
SAMSRITA
₹17.59+₹0.94 (5.65%) Past YearLast updated on 26 Apr, 2024 | 10:03 AM IST
₹16.60₹17.65
LH
What’s in news?
No data available at the moment
Company overview
About
Market cap
| Open₹16.63 | Close₹16.65 |
Circuit range₹19.98 - ₹13.32 | Day range₹16.60 - ₹17.65 | Year range₹13.00 - ₹24.50 |
Volume505 | Avg. traded₹16.62 | Revenue (12m)₹0 Cr |
SAMSRITA LABS LIMITEDSamsrita Labs Ltd is an India-based biopharma company. The Company is engaged activities, such as trading, exports and imports, manufacturing of bulk drugs, APIs, Specialty drugs, research and development (R&D) through joint ventures or associations or mergers or by its own. It has established platforms in the areas of stem cell research and therapy, new drug discovery, molecular prognosis and diagnostics services, CRO, stem cell focused super specialty hospital, RNA interference technology and medical devices. Its Stem Cell R&D division specializes in stem cell research and therapy, regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology, stem cell and cord blood banking. Its New Drug Discovery division is focused on working on five therapeutic areas of Wilson's disease, non-alcoholic steatohepatitis, neuropathic pain, cardiovascular diseases, cystinosis and Huntington's disease.
Read more
SAMSRITA LABS LIMITED Key indicators
52 week high₹24.50 | 52 week low₹13.00 | P/E ratio |
P/B ratio1.96 | ROE-5.45% | ROCE-4.59% |
Dividend yield-- | Debt/Equity ratio0.16 | EPS-0.48 |
Learn more
Featured in
Investment checklist: (1/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin-3237.31% | Net profit margin-3260.39% |
ROE-5.45% | ROA-4.3% |
ROCE-4.59% |
Learn more
Revenue statement
All values are in ₹ Crores (Cr)No data available at the moment
Cash flow
All values are in ₹ Crores (Cr)No data available at the moment
Balance sheet
All values are in ₹ Crores (Cr)No data available at the moment
SAMSRITA LABS LIMITED Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Apr 25 2024 | ₹16.91 | ₹16.65 | -1.56% |
Wed, Apr 24 2024 | ₹17.00 | ₹17.25 | |
Tue, Apr 23 2024 | ₹16.98 | ₹16.64 | -2.04% |
Mon, Apr 22 2024 | ₹16.85 | ₹16.65 | -1.20% |
Fri, Apr 19 2024 | ₹16.95 | ₹16.85 | -0.59% |
Thu, Apr 18 2024 | ₹14.12 | ₹16.66 | |
Tue, Apr 16 2024 | ₹14.10 | ₹15.01 | |
Mon, Apr 15 2024 | ₹14.55 | ₹15.61 |
Events
No data available at the moment